High Beta - Max Sharpe Optimization
Asset Allocation
Position | Category/Sector | Target Weight |
---|---|---|
ACGL Arch Capital Group Ltd. | Financial Services | 16.70% |
AVGO Broadcom Inc. | Technology | 7.60% |
ELF e.l.f. Beauty, Inc. | Consumer Defensive | 2.70% |
LLY Eli Lilly and Company | Healthcare | 31.90% |
NVDA NVIDIA Corporation | Technology | 6% |
NVO Novo Nordisk A/S | Healthcare | 31.90% |
SMCI Super Micro Computer, Inc. | Technology | 3.20% |
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in High Beta - Max Sharpe Optimization, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced every 3 months.
The earliest data available for this chart is Sep 22, 2016, corresponding to the inception date of ELF
Returns By Period
YTD | 1M | 6M | 1Y | 5Y* | 10Y* | |
---|---|---|---|---|---|---|
^GSPC S&P 500 | -10.18% | -5.91% | -9.57% | 5.19% | 12.98% | 9.68% |
High Beta - Max Sharpe Optimization | -14.17% | -8.63% | -22.18% | -6.25% | 43.32% | N/A |
Portfolio components: | ||||||
LLY Eli Lilly and Company | 8.99% | 2.12% | -8.10% | 12.61% | 41.64% | 30.23% |
NVO Novo Nordisk A/S | -31.39% | -27.12% | -50.08% | -52.43% | 14.90% | 9.99% |
ACGL Arch Capital Group Ltd. | 0.24% | -0.78% | -10.07% | 7.41% | 29.17% | 16.79% |
AVGO Broadcom Inc. | -26.02% | -9.10% | -5.27% | 34.94% | 48.99% | 33.58% |
NVDA NVIDIA Corporation | -24.42% | -12.08% | -25.87% | 20.80% | 69.58% | 69.23% |
SMCI Super Micro Computer, Inc. | 3.36% | -16.87% | -33.79% | -67.19% | 70.87% | 23.92% |
ELF e.l.f. Beauty, Inc. | -58.06% | -17.24% | -51.22% | -68.33% | 38.45% | N/A |
Monthly Returns
The table below presents the monthly returns of High Beta - Max Sharpe Optimization, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | -3.96% | 6.82% | -12.93% | -3.93% | -14.17% | ||||||||
2024 | 17.48% | 20.28% | 8.38% | -3.27% | 10.06% | 9.84% | -7.90% | 4.96% | -4.50% | -1.74% | 0.38% | -2.23% | 59.45% |
2023 | 3.10% | 2.50% | 11.60% | 7.04% | 13.93% | 7.90% | 3.85% | 10.66% | -5.28% | 0.68% | 8.33% | 2.45% | 88.76% |
2022 | -11.60% | 1.32% | 10.60% | -8.53% | 3.18% | -3.97% | 6.13% | -8.10% | -3.13% | 12.34% | 10.67% | -0.25% | 5.20% |
2021 | 6.09% | 3.04% | -3.61% | 4.20% | 6.67% | 11.52% | 4.06% | 8.36% | -7.08% | 14.30% | 6.27% | 3.58% | 72.18% |
2020 | 3.90% | -4.90% | -1.88% | 7.01% | 6.78% | 4.82% | -0.21% | 6.42% | 1.17% | -7.64% | 8.97% | 7.62% | 35.15% |
2019 | 4.62% | 6.28% | 6.11% | -3.71% | -6.52% | 5.50% | -1.06% | 3.97% | 0.90% | 4.71% | 3.42% | 6.36% | 33.94% |
2018 | 3.69% | -4.81% | -2.37% | -1.83% | 5.45% | -2.33% | 8.27% | 4.43% | 0.02% | -8.77% | 3.06% | -3.98% | -0.53% |
2017 | 2.73% | 3.25% | 1.39% | 2.06% | 5.87% | 0.63% | 2.67% | 3.58% | 1.97% | 2.53% | 1.76% | -0.94% | 31.05% |
2016 | -2.95% | -7.27% | 0.22% | 7.06% | -3.45% |
Expense Ratio
High Beta - Max Sharpe Optimization has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of High Beta - Max Sharpe Optimization is 2, meaning it’s performing worse than 98% of other portfolios on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Martin ratio | |
---|---|---|---|---|---|
LLY Eli Lilly and Company | 0.37 | 0.79 | 1.10 | 0.54 | 1.11 |
NVO Novo Nordisk A/S | -1.25 | -1.92 | 0.75 | -0.87 | -1.81 |
ACGL Arch Capital Group Ltd. | 0.28 | 0.55 | 1.07 | 0.32 | 0.68 |
AVGO Broadcom Inc. | 0.48 | 1.15 | 1.15 | 0.73 | 2.19 |
NVDA NVIDIA Corporation | 0.27 | 0.79 | 1.10 | 0.44 | 1.20 |
SMCI Super Micro Computer, Inc. | -0.59 | -0.57 | 0.93 | -0.80 | -1.34 |
ELF e.l.f. Beauty, Inc. | -0.98 | -1.70 | 0.80 | -0.89 | -1.54 |
Dividends
Dividend yield
High Beta - Max Sharpe Optimization provided a 2.09% dividend yield over the last twelve months.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Portfolio | 2.09% | 1.73% | 0.70% | 0.96% | 1.00% | 1.39% | 1.59% | 1.67% | 1.62% | 2.28% | 1.33% | 1.73% |
Portfolio components: | ||||||||||||
LLY Eli Lilly and Company | 0.64% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.95% | 2.46% | 2.77% | 2.37% | 2.84% |
NVO Novo Nordisk A/S | 2.78% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
ACGL Arch Capital Group Ltd. | 5.40% | 5.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AVGO Broadcom Inc. | 1.31% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% | 1.22% |
NVDA NVIDIA Corporation | 0.03% | 0.02% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% | 1.70% |
SMCI Super Micro Computer, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ELF e.l.f. Beauty, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the High Beta - Max Sharpe Optimization. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the High Beta - Max Sharpe Optimization was 33.23%, occurring on Apr 4, 2025. The portfolio has not yet recovered.
The current High Beta - Max Sharpe Optimization drawdown is 29.58%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-33.23% | Jul 11, 2024 | 185 | Apr 4, 2025 | — | — | — |
-27.99% | Feb 20, 2020 | 23 | Mar 23, 2020 | 52 | Jun 5, 2020 | 75 |
-19.55% | Dec 28, 2021 | 188 | Sep 26, 2022 | 42 | Nov 23, 2022 | 230 |
-16.01% | Oct 3, 2018 | 57 | Dec 24, 2018 | 45 | Mar 1, 2019 | 102 |
-14.71% | Mar 8, 2024 | 30 | Apr 19, 2024 | 24 | May 23, 2024 | 54 |
Volatility
Volatility Chart
The current High Beta - Max Sharpe Optimization volatility is 17.56%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Diversification
Asset Correlations Table
ACGL | LLY | ELF | NVO | SMCI | NVDA | AVGO | |
---|---|---|---|---|---|---|---|
ACGL | 1.00 | 0.21 | 0.24 | 0.18 | 0.22 | 0.18 | 0.21 |
LLY | 0.21 | 1.00 | 0.16 | 0.43 | 0.19 | 0.21 | 0.23 |
ELF | 0.24 | 0.16 | 1.00 | 0.17 | 0.29 | 0.29 | 0.30 |
NVO | 0.18 | 0.43 | 0.17 | 1.00 | 0.20 | 0.25 | 0.24 |
SMCI | 0.22 | 0.19 | 0.29 | 0.20 | 1.00 | 0.41 | 0.39 |
NVDA | 0.18 | 0.21 | 0.29 | 0.25 | 0.41 | 1.00 | 0.63 |
AVGO | 0.21 | 0.23 | 0.30 | 0.24 | 0.39 | 0.63 | 1.00 |